Evidence map›Paper›PMID 34229672›Full record

ArticleBMC women's health2021

Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana.

Tara M Friebel-Klingner, Rebecca Luckett, Lisa Bazzett-Matabele, Tlotlo B Ralefala, Barati Monare, Mercy Nkuba Nassali, Doreen Ramogola-Masire, Memory Bvochora, Nandita Mitra, Douglas Wiebe and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC women's health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Tara M Friebel-KlingnerDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Rebecca LuckettDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
Lisa Bazzett-MatabeleDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
Tlotlo B RalefalaDepartment of Oncology, Princess Marina Hospital, Gaborone, Botswana.
Barati MonareBotswana-University of Pennsylvania Partnership, Gaborone, Botswana.
Mercy Nkuba NassaliDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
Doreen Ramogola-MasireDepartment of Obstetrics and Gynecology, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
Memory BvochoraDepartment of Oncology, Princess Marina Hospital, Gaborone, Botswana.
Nandita MitraDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Douglas WiebeDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Timothy R RebbeckDana-Farber Cancer Institute and Harvard TH Chan School of Public Health, Boston, MA, USA.
Anne Marie McCarthy *Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Surbhi Grover *Botswana-University of Pennsylvania Partnership, Gaborone, Botswana. surbhi.grover@pennmedicine.upenn.edu.
University of Pennsylvania · USUniversity of Botswana · BWBeth Israel Deaconess Medical Center · USDana-Farber Cancer Institute · USYale University · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI ROBERT GROSS · 1999 to 2026
$78.6M
Prognostic value of quantitative HPV viral load in determining cervical cancer treatment response and recurrenceK08CA230170 · NCI · UNIVERSITY OF PENNSYLVANIA · PI GROVER, SURBHI · 2019 to 2023
$1.4M
NCI NIH HHS K08 CA230170NIAID NIH HHS P30 AI045008
6 · The paper itself

Abstract

backgroundCervical cancer is the leading cause of female cancer mortality in Botswana with the majority of cervical cancer patients presenting with late-stage disease. The identification of factors associated with late-stage disease could reduce the cervical cancer burden. This study aims to identify potential patient level clinical and sociodemographic factors associated with a late-stage diagnosis of cervical cancer in Botswana in order to help inform future interventions at the community and individual levels to decrease cervical cancer morbidity and mortality.

resultsThere were 984 women diagnosed with cervical cancer from January 2015 to March 2020 at two tertiary hospitals in Gaborone, Botswana. Four hundred forty women (44.7%) presented with late-stage cervical cancer, and 674 women (69.7%) were living with HIV. The mean age at diagnosis was 50.5 years. The association between late-stage (III/IV) cervical cancer at diagnosis and patient clinical and sociodemographic factors was evaluated using multivariable logistic regression with multiple imputation. Women who reported undergoing cervical cancer screening had lower odds of late-stage disease at diagnosis (OR: 0.63, 95% CI 0.47-0.84) compared to those who did not report screening. Women who had never been married had increased odds of late-stage disease at diagnosis (OR: 1.35, 95% CI 1.02-1.86) compared to women who had been married. Women with abnormal vaginal bleeding had higher odds of late-stage disease at diagnosis (OR: 2.32, 95% CI 1.70-3.16) compared to those without abnormal vaginal bleeding. HIV was not associated with a diagnosis of late-stage cervical cancer. Rural women who consulted a traditional healer had increased odds of late-stage disease at diagnosis compared to rural women who had never consulted a traditional healer (OR: 1.61, 95% CI 1.02-2.55).

conclusionIncreasing education and awareness among women, regardless of their HIV status, and among providers, including traditional healers, about the benefits of cervical cancer screening and about the importance of seeking prompt medical care for abnormal vaginal bleeding, while also developing support systems for unmarried women, may help reduce cervical cancer morbidity and mortality in Botswana.

Indexed as

Uterine Cervical NeoplasmsBotswanaDelayed DiagnosisEarly Detection of CancerFemaleHumansMass ScreeningBotswanaCervical cancerHIVLate-stage

Identifiers

PMID34229672
PMCPMC8259023
OpenAlexW3181724042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.